Concepedia

Kapil Suchal

KS

Statistics

Publications

16

Citations

1.3K

H-Index

16

Active since

2014

Affiliations

All India Institute of Medical Sciences(Current)

Shri Vile Parle Kelavani Mandal

United Arab Emirates University

Johns Hopkins Medicine

Johns Hopkins University

Kapil Suchal is an author at All India Institute of Medical Sciences specializing in pharmacology, medicine, and inflammation.

Publications per year

2014–2020

16

Publications

16

Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways

Salma Malik, Kapil Suchal, Sana Irfan Khan et al. · American Journal of Physiology-Renal Physiology · 2017 · 239 citations

, , +17

Telmisartan ameliorates cisplatin-induced nephrotoxicity by inhibiting MAPK mediated inflammation and apoptosis

Salma Malik, Kapil Suchal, Nanda Gamad et al. · European Journal of Pharmacology · 2014 · 115 citations

, , +12

Kaempferol Attenuates Myocardial Ischemic Injury <i>via</i> Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia‐Reperfusion Injury

Kapil Suchal, Salma Malik, Nanda Gamad et al. · Oxidative Medicine and Cellular Longevity · 2016 · 112 citations · Full text

, , +16

Molecular Pathways Involved in the Amelioration of Myocardial Injury in Diabetic Rats by Kaempferol

Kapil Suchal, Salma Malik, Sana Irfan Khan et al. · International Journal of Molecular Sciences · 2017 · 107 citations · Full text

, , +15

Protective effect of mangiferin on myocardial ischemia-reperfusion injury in streptozotocin-induced diabetic rats: role of AGE-RAGE/MAPK pathways

Kapil Suchal, Salma Malik, Sana Irfan Khan et al. · Scientific Reports · 2017 · 97 citations · Full text

, , +17

1–5 of 16